1. A cable comprising:
a conductor keeper made of plastic, being elongated and having
two end surfaces;
an annular surface; and
multiple grooves formed longitudinally in the annular surface of the conductor keeper and formed through two end surfaces of the conductor keeper;
multiple bare conductors made of metal, each bare conductor mounted in one of the grooves of the conductor keeper and having a first end and a second end and the first end and second end of the bare conductor protruding out of the two end surfaces of the conductor keeper respectively so as to form two spaces between the first ends and second ends of the bare conductors;
a dielectric tape wrapped around the annular surface of the conductor keeper;
a plastic jacket coated around the dielectric tape; and
two copper cylinders mounted in the spaces of the bare conductors respectively to make the bare conductors surround the copper cylinders and the bare conductors connect to each other in parallel;
wherein each copper cylinder has
two end surfaces;
an annular surface; and
multiple recesses formed longitudinally in the annular surface of the copper cylinder, formed through two end surfaces of the copper cylinder, aligning respectively with the grooves of the conductor keeper and holding respectively the ends of the bare conductors inside; and
wherein each bare conductor is circular in cross section and has a radian corresponding to a radian of the corresponding groove of the conductor keeper.
2. The cable as claimed in claim 1 further comprising two terminals mounted on the first ends and second ends of the bare conductors respectively.
3. The cable as claimed in claim 2, wherein each terminal has
a collar and the two collars mounted around the first ends and second ends of the bare conductors respectively; and
a mounting unit protruding from the collar.
4. The cable as claimed in claim 1, wherein
the conductor keeper further has a through hole formed through the conductor keeper; and
each copper cylinder further has a central hole formed through the copper cylinder and aligning with the through hole of the conductor keeper.
5. The cable as claimed in claim 1, wherein the conductor keeper is triangular in cross section.
6. The cable as claimed in claim 1, wherein the conductor keeper is circular in cross section.
7. The cable as claimed in claim 1, wherein the conductor keeper is made of plastic.
8. The cable as claimed in claim 1, wherein the bare conductors are copper wires.
9. The cable as claimed in claim 1, wherein the bare conductors are copper-clad steel wires.
10. The cable as claimed in claim 1, wherein the bare conductors are copper-clad aluminum wires.
11. The cable as claimed in claim 1, wherein the bare conductors are aluminum wires.
12. The cable as claimed in claim 1, wherein the dielectric tape is made of polyethylene.
13. The cable as claimed in claim 1, wherein the dielectric tape is paper.
14. The cable as claimed in claim 1, wherein the plastic jacket is made of polyvinyl chloride.
15. The cable as claimed in claim 1, wherein the plastic jacket is a halogen-free insulation.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. A compound of Formula I:
wherein X is CH2; Y is C1-C6 alkylene; and R is selected from the group consisting of hydrogen, C1-C6 alkyl,
wherein R1 is selected from the group consisting of H, OH, COOH, C1-C6 alkyl, alkenyl, alkynyl, and C1-C6-hydroxyalkyl; R2 is OH;
or a salt thereof.
2. The compound of claim 1, wherein R is hydrogen.
3. The compound of claim 1, wherein R is C1-C6 alkyl.
4. The compound of claim 1, wherein R is
5. The compound of claim 4, wherein R1 is H.
6. The compound of claim 4, wherein R1 is COOH.
7. The compound of claim 4, wherein R1 is CH2OH.
8. The compound of claim 4, wherein R1 is OH.
9. The compound of claim 1, wherein R is
10. A pharmaceutical composition for inhibiting formation of breast cancer and treating breast cancer in mammals, the composition comprising an effective breast cancer cell growth-inhibiting amount of a compound according to claim 1, or a pharmaceutically-suitable salt thereof, optionally in combination with a pharmaceutically-suitable carrier.
11. A method of inhibiting formation of breast cancer and treating breast cancer in mammals, the method comprising administering a breast cancer cell growth-inhibiting amount of a compound according to claim 1, or a pharmaceutically-suitable salt thereof, to a patient in need thereof.